- Trials with a EudraCT protocol (787)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
787 result(s) found for: Plasma volume.
Displaying page 1 of 40.
EudraCT Number: 2013-004446-42 | Sponsor Protocol Number: AIR | Start Date*: 2014-02-09 |
Sponsor Name:Skåne University Hospital | ||
Full Title: THE IMPORTANCE OF ALBUMIN INFUSION RATE FOR PLASMA VOLUME EXPANSION FOLLOWING MAJOR ABDOMINAL SURGERY | ||
Medical condition: Post operative patients who have been subjected to either a non-emergant Whipple operation or major gynecological cancer surgery ( including resection of ovaries, uterus, adnexa, oment and lymph ... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-005175-10 | Sponsor Protocol Number: ABD03 | Start Date*: 2009-04-08 | |||||||||||
Sponsor Name:Guys and St Thomas' NHS Foudation Trust | |||||||||||||
Full Title: Volume Expansion using a balanced gelatin solution in patients undergoing major abdominal surgery. | |||||||||||||
Medical condition: Intravascular volume deficits in major abdominal surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-018343-34 | Sponsor Protocol Number: 09P07 | Start Date*: 2011-10-25 | |||||||||||
Sponsor Name:Ludwigs Maximilians University | |||||||||||||
Full Title: Comparison of 6% Hydroxyethyl Starch and 5% Albumin for Volume Replacement Therapy in Patients Undergoing Cystectomy (CHART study) | |||||||||||||
Medical condition: Comparison of 6% Hydroxyethyl Starch and 5% Albumin for Volume Replacement Therapy in Patients Undergoing Cystectomy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-004175-22 | Sponsor Protocol Number: HC-G-H-0803 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:B. Braun Melsungen AG | |||||||||||||
Full Title: PROSPECTIVE, CONTROLLED, DOUBLE-BLIND, RANDOMIZED MULTICENTRIC STUDY ON THE EFFICACY AND SAFETY OF A TARGET CONTROLLED PLASMA VOLUME REPLACEMENT THERAPY WITH A HYPER-ONCOTIC BALANCED HES 130/0.42... | |||||||||||||
Medical condition: Intraoperative plasma volume replacement requirement in elective surgery of the pancreatic head (pylorus preserving pancreatic-duodenectomy, PPPD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004512-11 | Sponsor Protocol Number: FJD-VITDAMI-14-01 | Start Date*: 2015-08-06 |
Sponsor Name:INSTITUTO DE INVESTIGACION SANITARIA FJD | ||
Full Title: Multicenter, randomized, double-blind, placebo-controlled study to evaluate the effect of vitamin D on ventricular remodeling in patients with acute myocardial infarction: Test VITDAMI (Vitamin D i... | ||
Medical condition: Acute myocardial infarction with ST segment elevation anterior | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-002096-16 | Sponsor Protocol Number: 01/04 | Start Date*: 2005-05-23 |
Sponsor Name:Universitätskinderklinik Innsbruck | ||
Full Title: Effect of plasma volume expansion with hydroxy-ethyl-starch (HES) 130/0.4 or crystalloids on interstitial fluid accumulation and blood pressure in newborn infants with arterial hypotension | ||
Medical condition: Arterial hypotension | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2015-004207-22 | Sponsor Protocol Number: CLCZ696B2319 | Start Date*: 2017-04-06 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: Multicenter, open-label, study to evaluate safety, tolerability, pharmacokinetics and, pharmacodynamics of LCZ696 followed by a 52-week randomized, double-blind, parallel group, active-controlled s... | |||||||||||||
Medical condition: Pediatric heart failure 1 month to <18 years old | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) FI (Completed) NL (Ongoing) SE (Completed) NO (Completed) ES (Completed) GB (GB - no longer in EU/EEA) CZ (Completed) IT (Completed) FR (Completed) BG (Completed) PL (Completed) HU (Completed) HR (Completed) AT (Completed) PT (Completed) RO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-000996-26 | Sponsor Protocol Number: VAB1 | Start Date*: 2016-09-01 |
Sponsor Name:Region Ostergotland | ||
Full Title: Volumekinetics for hyperoncotic albumin in burn patients as well as for healthy subjects. | ||
Medical condition: Healthy adult volunteers and burn patients 3 to 10 Days after the injury. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-001840-37 | Sponsor Protocol Number: 2017-001840-37 | Start Date*: 2019-01-15 |
Sponsor Name:VU University Medical Center | ||
Full Title: ERtugliflozin triAl in DIabetes with preserved or reduced ejeCtion FrAcTion mEchanistic evaluation in Heart Failure: "ERADICATE-HF" | ||
Medical condition: Diabetes Mellitus Type 2 and Heart failure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-000861-34 | Sponsor Protocol Number: 2021-000861-34 | Start Date*: 2022-07-01 |
Sponsor Name:Region Ostergotland | ||
Full Title: Comparison of albumin and Ringer´s solution for optimization of the plasma volume and hemodynamics during surgery. | ||
Medical condition: Patients in need of major laparoscopic surgery in the abdomen, lasting longer than 90 minutes | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2012-003398-24 | Sponsor Protocol Number: FP2012/01 | Start Date*: 2012-10-29 | ||||||||||||||||
Sponsor Name:FUNDACIÓ PUIGVERT | ||||||||||||||||||
Full Title: Randomized clinical trial to compare the effect of mannitol and hydroelectrolytic solutions as kidney function protector, in partial laparoscopic nephrectomies (MANCOL Study) | ||||||||||||||||||
Medical condition: partial laparoscopic nephrectomy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001135-20 | Sponsor Protocol Number: Albumin | Start Date*: 2015-04-28 |
Sponsor Name:Södertälje sjukhus AB | ||
Full Title: Volume kinetics for 20% albumin in conscious and anaesthetized humans with and without inflammation. | ||
Medical condition: Healthy adult volunteers, healthy patients undergoing surgery under general anesthesia, and patients in a state of inflammation after having undergone surgery under general anaesthesia (within 24 h... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-002162-30 | Sponsor Protocol Number: HC-G-H-1504 | Start Date*: 2017-04-12 | |||||||||||
Sponsor Name:Fresenius Kabi Deutschland GmbH | |||||||||||||
Full Title: Prospective, randomized, controlled, double-blind, multicentre, multinational study on the safety and efficacy of 6% Hydroxyethyl starch (HES) solution versus an electrolyte solution in patients u... | |||||||||||||
Medical condition: Hypovolaemia due to acute blood loss in elective abdominal surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) CZ (Completed) NL (Completed) ES (Restarted) FR (Ongoing) AT (Completed) HR (Completed) RO (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-001856-16 | Sponsor Protocol Number: 35RC17_9804_REVOLUMHOD | Start Date*: 2020-09-08 | |||||||||||
Sponsor Name:Rennes University Hospital | |||||||||||||
Full Title: Evaluation of the Relationship Between Anti-PD-1 Exposure and Tumor VOLUME in Patients Treated for Conventional HODgkin's Lymphoma | |||||||||||||
Medical condition: Refractory Hodgkin Lymphoma | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-002122-30 | Sponsor Protocol Number: 1978 | Start Date*: 2007-09-14 | |||||||||||||||||||||
Sponsor Name:Medical University Vienna Division of Anesthesie and Pain Management | |||||||||||||||||||||||
Full Title: The effect of different solvents of HES preparations on coagulation and platelet function (Effekt der Trägerlösung von HES Präparaten auf Blutgerinnung und Thrombozytenfunktion) | |||||||||||||||||||||||
Medical condition: treatment and prophylaxis of acute hypovolaemia and shock acute normovolaemic haemodilution | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||||||||||||
Trial protocol: AT (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-001558-87 | Sponsor Protocol Number: UBS-HG | Start Date*: 2014-02-24 |
Sponsor Name:Karolinska University Hospital | ||
Full Title: Safety of normalising slightly elevated plasma glucose by Exenatide in acute ischemic stroke patients treated with intravenous thrombolysis: a pilot study | ||
Medical condition: Patients with acute ischemic stroke, treated with intravenous thrombolysis treatment according to the European regulatory criteria | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2016-002176-27 | Sponsor Protocol Number: HC-G-H-1505 | Start Date*: 2017-08-30 | |||||||||||
Sponsor Name:Fresenius Kabi Deutschland GmbH | |||||||||||||
Full Title: Pragmatic, prospective, randomized, controlled, double-blind, multicentre, multinational study on the safety and efficacy of a 6% Hydroxyethyl starch (HES) solution versus an electrolyte solution ... | |||||||||||||
Medical condition: Hypovolaemia due to acute blood loss in trauma surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BE (Completed) CZ (Completed) NL (Completed) ES (Restarted) FR (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-009134-32 | Sponsor Protocol Number: 2137/09 | Start Date*: 2009-04-27 |
Sponsor Name:North Bristol NHS Trust | ||
Full Title: Bristol Randomised Controlled Trial of Zoledronic Acid in Malignant Pleural disease(Pilot Study). | ||
Medical condition: Malignant pleural disease of all histological cell types. 50% patients in trial will have indwelling pleural catheters for management of breathlessness. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-002550-39 | Sponsor Protocol Number: PDY13949 | Start Date*: 2016-10-20 | ||||||||||||||||
Sponsor Name:Genzyme Corporation | ||||||||||||||||||
Full Title: 4-part, open-label, multicenter, multinational study of the safety, tolerability, pharmacokinetics, pharmacodynamic, and exploratory efficacy of venglustat in combination with Cerezyme in adult pat... | ||||||||||||||||||
Medical condition: Gaucher disease | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003709-25 | Sponsor Protocol Number: PRPVol | Start Date*: 2019-06-11 |
Sponsor Name:Hospital Son Llatzer | ||
Full Title: Value of ultrasound-guided treatment with Platelet Rich Plasma or high volume injection in the rotator cuff tendon: Prospective randomized clinical trial. EudraCT number 2018-003709-25 | ||
Medical condition: Shoulder pain due to rotator cuff tendinopathy or partial tears of the supraspinatus tendon | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
